Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS)
Y Shimojima, D Kishida, T Ichikawa, T Kida… - Arthritis Research & …, 2022 - Springer
Background This study investigated the characteristics of hypertrophic pachymeningitis (HP)
in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), using …
in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), using …
Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti‐neutrophil cytoplasmic antibody …
Y Shimojima, D Kishida, A Hineno… - International Journal …, 2017 - Wiley Online Library
Aim To elucidate the characteristics of patients with hypertrophic pachymeningitis (HP) in a
population with anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) …
population with anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) …
Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort …
K Sada, M Yamamura, M Harigai, T Fujii… - Arthritis research & …, 2014 - Springer
Introduction We investigated the clinical and serological features of patients with
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in Japan using data …
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in Japan using data …
Cutaneous manifestations of antineutrophil cytoplasmic antibody–associated vasculitis
RG Micheletti, Z Chiesa Fuxench… - Arthritis & …, 2020 - Wiley Online Library
Objective Cutaneous manifestations of antineutrophil cytoplasmic antibody (ANCA)–
associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic …
associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic …
Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and …
A Imafuku, N Sawa, M Kawada, R Hiramatsu… - Clinical …, 2019 - Springer
Objectives Hypertrophic pachymeningitis (HP) is a rare complication in patients with anti-
neutrophil antibody-associated vasculitis (AAV); its clinical features, incidence, and risk …
neutrophil antibody-associated vasculitis (AAV); its clinical features, incidence, and risk …
Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients
T Sakairi, N Sakurai, M Nakasatomi… - Scandinavian Journal …, 2019 - Taylor & Francis
Objective: We aimed to describe the clinical characteristics and treatment course of
hypertrophic pachymeningitis (HPM) in patients with antineutrophil cytoplasmic antibody …
hypertrophic pachymeningitis (HPM) in patients with antineutrophil cytoplasmic antibody …
Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
H Wu, Y Lu, R Hu, W Ye, Y Wen, J Cai, H Li, X Li - BMC nephrology, 2022 - Springer
Background Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may
coexist with rheumatoid arthritis (RA). However, it is unclear whether the manifestations of …
coexist with rheumatoid arthritis (RA). However, it is unclear whether the manifestations of …
Large-vessel involvement in ANCA-associated vasculitis: A multicenter case-control study
V Monghal, X Puéchal, P Smets… - Seminars in Arthritis and …, 2024 - Elsevier
Objective Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) primarily
affects small vessels. Large-vessel involvement (LVI) is rare. We aimed to describe the …
affects small vessels. Large-vessel involvement (LVI) is rare. We aimed to describe the …
[PDF][PDF] Efficacy of rituximab for anti-neutrophil cytoplasmic antibody-associated hypertrophic pachymeningitis: a case series
K Kobayashi, D Nakagomi, S Furuta… - Clin Exp …, 2020 - clinexprheumatol.org
Objective. This study researched the efficacy of rituximab (RTX) in patients with anti-
neutrophil cytoplasmic antibody (ANCA)-associated hypertrophic pachymeningitis (HP) …
neutrophil cytoplasmic antibody (ANCA)-associated hypertrophic pachymeningitis (HP) …
Seasonal influence on development of antineutrophil cytoplasmic antibody–associated vasculitis: a retrospective cohort study conducted at multiple institutions in …
Y Yoshida, N Nakamoto, N Oka, G Kidoguchi… - The Journal of …, 2023 - jrheum.org
Objective To clarify seasonal and other environmental effects on the onset of antineutrophil
cytoplasmic antibody (ANCA)–associated vasculitis (AAV). Methods We enrolled patients …
cytoplasmic antibody (ANCA)–associated vasculitis (AAV). Methods We enrolled patients …
相关搜索
- hypertrophic pachymeningitis associated vasculitis
- hypertrophic pachymeningitis characteristic manifestation
- hypertrophic pachymeningitis cytoplasmic antibody
- characteristic manifestation associated vasculitis
- cytoplasmic antibody associated vasculitis
- hypertrophic pachymeningitis granulomatosis with polyangiitis
- granulomatosis with polyangiitis associated vasculitis
- hypertrophic pachymeningitis logistic regression
- hypertrophic pachymeningitis efficacy of rituximab
- seasonal influence associated vasculitis
- subgroup analysis associated vasculitis
- rheumatoid arthritis associated vasculitis
- cutaneous manifestations associated vasculitis